Events List‎ > ‎

ETH Alumni New England Chapter Annual Party

ETH Alumni New England Chapter Annual Party
with Keynote Speaker Prof. Bob Langer, MIT


 Dear ETH Alum,

We would like to invite you to come celebrate ETH Alumni New England Chapter's first year of existence. It will be a great opportunity to see again other ETH alumni living in the New England region and to make new connections. Professor Bob Langer of MIT who received a honorary doctorate from ETH Zurich will deliver the keynote address and talk about his work on drug delivery systems and tissue engineering, and its commercialization. His speech will be followed by a cocktail reception.


Robert S. Langer is the David H. Koch Institute Professor at MIT in the Departments of Chemical and Biomedical Engineering (there are only 14 Institute Professors at MIT). Dr. Langer has written nearly 1,130 articles. He also has approximately 800 issued and pending patents worldwide.  Dr. Langer’s patents have been licensed or sublicensed to over 220 pharmaceutical, chemical, biotechnology and medical device companies, about two dozen of which he took a key role in founding. He is the most cited engineer in history.


Join Professor Langer and other ETH alumni at 6:30pm on Wednesday, November 2nd at Swissnex Boston 420 Broadway Cambridge, MA 02138.
Click here to RSVP.

Lecture Preview:

Biomaterials and biotechnology:  From the discovery of the first angiogenesis inhibitors to the development of controlled drug delivery systems and the foundation of tissue engineering

 

Advanced drug delivery systems are having an enormous impact on human health.  We start by discussing our early research on developing the first controlled release systems for macromolecules and the isolation of angiogenesis inhibitors and how these led to numerous new therapies.  For example, new drug delivery technologies including nanoparticles and nanotechnology are now being studied for use treating cancer and other illnesses.  We then discuss new ways of using nanotechnology to deliver DNA and siRNA and novel microchips for drug delivery.  Approaches for creating new biomaterials are then evaluated and examples where such materials are used in brain cancer and shape memory applications are discussed.  Finally, by combining mammalian cells, including stem cells, with synthetic polymers, new approaches for engineering tissues are being developed that may someday help in various disease.  Examples in the areas of cartilage, skin and spinal cord repair are discussed.
Comments